CZ211299A3 - Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů - Google Patents

Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů Download PDF

Info

Publication number
CZ211299A3
CZ211299A3 CZ992112A CZ211299A CZ211299A3 CZ 211299 A3 CZ211299 A3 CZ 211299A3 CZ 992112 A CZ992112 A CZ 992112A CZ 211299 A CZ211299 A CZ 211299A CZ 211299 A3 CZ211299 A3 CZ 211299A3
Authority
CZ
Czechia
Prior art keywords
factor
derivative
vvf
von
von villebrand
Prior art date
Application number
CZ992112A
Other languages
Czech (cs)
English (en)
Inventor
Hans-Peter Schwarz
Peter Turecek
Johann Eibl
Original Assignee
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Aktiengesellschaft filed Critical Baxter Aktiengesellschaft
Publication of CZ211299A3 publication Critical patent/CZ211299A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
CZ992112A 1996-12-13 1997-11-19 Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů CZ211299A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0217896A AT405740B (de) 1996-12-13 1996-12-13 Von willebrand-faktor-derivat sowie ein verfahren zur isolierung von proteinen

Publications (1)

Publication Number Publication Date
CZ211299A3 true CZ211299A3 (cs) 1999-09-15

Family

ID=3529390

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ992112A CZ211299A3 (cs) 1996-12-13 1997-11-19 Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů

Country Status (6)

Country Link
EP (1) EP0954533A1 (fr)
JP (1) JP2001506987A (fr)
AT (1) AT405740B (fr)
CZ (1) CZ211299A3 (fr)
HU (1) HUP9903789A3 (fr)
WO (1) WO1998025969A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994310A (en) * 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII
BRPI0519562A2 (pt) 2004-12-27 2009-01-27 Baxter Int construÇço proteinÁcea, complexo, mÉtodo para prolongar a meia-vida in vivo de fator viii (fviii) ou um derivado biologicamente ativo do mesmo composiÇço farmacÊutica, e, mÉtodo para formar uma construÇço proteinÁcea
CA2647314A1 (fr) 2006-03-31 2007-11-08 Baxter International Inc. Facteur viii pegyle
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
CA2740919A1 (fr) * 2008-10-21 2010-04-29 Baxter International Inc. Formulations de vwf recombinant lyophilise
JP2015507929A (ja) * 2012-02-14 2015-03-16 ポートラ ファーマシューティカルズ, インコーポレイテッド 第Xa因子阻害剤に対する組み換え拮抗剤を製作するためのプロセス

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
DE19521313A1 (de) * 1995-06-12 1996-12-19 Max Planck Inst Fuer Physiolog Verfahren zur affinitätschromatographischen Aufreinigung von Faktor VIII
SE9503380D0 (sv) * 1995-09-29 1995-09-29 Pharmacia Ab Protein derivatives

Also Published As

Publication number Publication date
HUP9903789A2 (hu) 2000-03-28
ATA217896A (de) 1999-03-15
AT405740B (de) 1999-11-25
HUP9903789A3 (en) 2002-01-28
JP2001506987A (ja) 2001-05-29
WO1998025969A1 (fr) 1998-06-18
EP0954533A1 (fr) 1999-11-10

Similar Documents

Publication Publication Date Title
US5880265A (en) Method for isolation of highly pure von willebrand factor
EP1863920B1 (fr) Procédé d'isolation ameliorée des protéines de recombinaison
AU645172B2 (en) Process for an industrial-scale preparation of a standardized human von Willebrand factor concentrate of very high purity and suitable for therapeutic use
CA1083959A (fr) Procede de production d'une immunoglobuline intraveineuse
FI101476B (fi) Menetelmä kalsiumista riippuvan proteiini C:n vastaisen monoklonaalise n vasta-aineen valmistamiseksi
US6005077A (en) Use of von willebrand factor and pharmaceutical formulation
JP4250769B2 (ja) 高度に精製されたvWFまたは因子VIII/vWF複合体を得る方法
JPS63152396A (ja) フォン・ウィレブラント因子の結合を抑制するペプチド
US4774323A (en) Purification of von Willebrand Factor solutions using gel permeation chromatography
WO2021062263A1 (fr) Procédés d'évaluation de polymères modifiés par un polypeptide dans des compositions
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
CZ211299A3 (cs) Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů
US5710254A (en) Purification of von Willebrand factor by affinity chromatography
US20020019036A1 (en) Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor
RU2734783C2 (ru) Способ отделения фактора viii от продуктов крови
EP0239644A1 (fr) Nouvelle substance physiologiquement active limitant la coagulation du sang
JP2778086B2 (ja) 第x▲iii▼因子のアフイニテイクロマトグラフイーによる精製法
CZ290186B6 (cs) Způsob výroby frakce s inaktivovanými viry obsahující faktor VIII chromatografickými metodami a frakce připravitelná tímto způsobem
Yamamoto et al. von Willebrand factor antigen in urine
EP1094077A1 (fr) Nouveau peptide lie par une chaine de sucres et similaire a la thrombomoduline
Thomas Studies on the third component of complement
de Lille Burnouf-Radosevich et a1.
MXPA97003470A (en) Factor v purification process

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic